Preproghrelin Leu72Met Polymorphism in Chinese Subjects with Coronary Artery Disease and Controls.

Na-Ping Tang,Lian-Sheng Wang,Li Yang,Hai-Juan Gu,Huai-Jun Zhu,Bo Zhou,Qing-Min Sun,Ri-Hong Cong,Bin Wang
DOI: https://doi.org/10.1016/j.cca.2007.08.014
IF: 6.314
2008-01-01
Clinica Chimica Acta
Abstract:Background: Ghrelin, a novel endogenous ligand for the growth hormone secretagogue receptor, is considered to exert a protective effect against atherosclerosis. The Leu72Met (+408C > A) polymorphic variant of the preproghrelin, the gene for the ghrelin precursor, has been linked to obesity, diabetes and metabolic syndrome. However, it is unclear whether this polymorphism is associated with coronary artery disease (CAD).Methods: We conducted a case-control study with 317 CAD patients and 323 controls to investigate the potential association of the Leu72Met polymorphism with the occurrence of CAD and CAD-related phenotypes in Chinese population.Results: No significant difference in the Leu72Met genotype frequency was observed between CAD patients and controls (P=NS). The Leu72Met polymorphism was not associated with hypertension, diabetes, dyslipidemia, the number of diseased vessels, plasma total cholesterol, triglyceride, high density lipoprotein cholesterol, low density lipoprotein cholesterol or fasting glucose levels in CAD patients. However, among CAD patients, those with variant genotypes (Leu72Met and Met:72Met) had lower BMI (24.4 +/- 0.3 kg/m(2)) than Leu72Leu carriers (25.4 +/- 0.2 kg/m(2), adjusted P=0.033).Conclusion: Our data indicate that the preproghrelin Leu72Met polymorphism is not associated with CAD in Chinese population. However, the Leu72Met variant is associated with BMI among CAD patients. C 2007 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?